-
Something wrong with this record ?
12-O-Tetradecanoylphorbol-13-acetate increases cardiomyogenesis through PKC/ERK signaling
KA. Radaszkiewicz, D. Beckerová, L. Woloszczuková, TW. Radaszkiewicz, P. Lesáková, OV. Blanářová, L. Kubala, P. Humpolíček, J. Pachernik,
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
Nature Open Access
from 2011-12-01
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
Springer Nature OA/Free Journals
from 2011-12-01
- MeSH
- Cell Differentiation drug effects MeSH
- Embryonic Stem Cells cytology drug effects metabolism MeSH
- Extracellular Signal-Regulated MAP Kinases metabolism MeSH
- Phosphorylation MeSH
- Myocytes, Cardiac cytology metabolism MeSH
- Mice MeSH
- Protein Kinase C metabolism MeSH
- Signal Transduction drug effects MeSH
- Tetradecanoylphorbol Acetate pharmacology MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
12-O-Tetradecanoylphorbol-13-acetate (TPA) is the most widely used diacylglycerol (DAG) mimetic agent and inducer of protein kinase C (PKC)-mediated cellular response in biomedical studies. TPA has been proposed as a pluripotent cell differentiation factor, but results obtained have been inconsistent. In the present study we show that TPA can be applied as a cardiomyogenesis-promoting factor for the differentiation of mouse embryonic stem (mES) cells in vitro. The mechanism of TPA action is mediated by the induction of extracellular signal-regulated kinase (ERK) activity and the subsequent phosphorylation of GATA4 transcription factor. Interestingly, general mitogens (FGF, EGF, VEGF and serum) or canonical WNT signalling did not mimic the effect of TPA. Moreover, on the basis of our results, we postulate that a TPA-sensitive population of cardiac progenitor cells exists at a certain time point (after days 6-8 of the differentiation protocol) and that the proposed treatment can be used to increase the multiplication of ES cell-derived cardiomyocytes.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20027809
- 003
- CZ-PrNML
- 005
- 20240717093507.0
- 007
- ta
- 008
- 210105s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-020-73074-4 $2 doi
- 035 __
- $a (PubMed)32985604
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Radaszkiewicz, Katarzyna $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic. $7 xx0320047
- 245 10
- $a 12-O-Tetradecanoylphorbol-13-acetate increases cardiomyogenesis through PKC/ERK signaling / $c KA. Radaszkiewicz, D. Beckerová, L. Woloszczuková, TW. Radaszkiewicz, P. Lesáková, OV. Blanářová, L. Kubala, P. Humpolíček, J. Pachernik,
- 520 9_
- $a 12-O-Tetradecanoylphorbol-13-acetate (TPA) is the most widely used diacylglycerol (DAG) mimetic agent and inducer of protein kinase C (PKC)-mediated cellular response in biomedical studies. TPA has been proposed as a pluripotent cell differentiation factor, but results obtained have been inconsistent. In the present study we show that TPA can be applied as a cardiomyogenesis-promoting factor for the differentiation of mouse embryonic stem (mES) cells in vitro. The mechanism of TPA action is mediated by the induction of extracellular signal-regulated kinase (ERK) activity and the subsequent phosphorylation of GATA4 transcription factor. Interestingly, general mitogens (FGF, EGF, VEGF and serum) or canonical WNT signalling did not mimic the effect of TPA. Moreover, on the basis of our results, we postulate that a TPA-sensitive population of cardiac progenitor cells exists at a certain time point (after days 6-8 of the differentiation protocol) and that the proposed treatment can be used to increase the multiplication of ES cell-derived cardiomyocytes.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a buněčná diferenciace $x účinky léků $7 D002454
- 650 _2
- $a embryonální kmenové buňky $x cytologie $x účinky léků $x metabolismus $7 D053595
- 650 _2
- $a extracelulárním signálem regulované MAP kinasy $x metabolismus $7 D048049
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a kardiomyocyty $x cytologie $x metabolismus $7 D032383
- 650 _2
- $a fosforylace $7 D010766
- 650 _2
- $a proteinkinasa C $x metabolismus $7 D011493
- 650 _2
- $a signální transdukce $x účinky léků $7 D015398
- 650 _2
- $a tetradekanoylforbolacetát $x farmakologie $7 D013755
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Beckerová, Deborah $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Woloszczuková, Lucie $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Radaszkiewicz, Tomasz Witold $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Lesáková, Petra $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Blanářová, Olga Vondálová $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Kubala, Lukáš $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic. Department of Free Radical Pathophysiology, Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic.
- 700 1_
- $a Humpolíček, Petr $u Centre of Polymer Systems and Faculty of Technology, Tomas Bata University in Zlin, 760 01, Zlin, Czech Republic.
- 700 1_
- $a Pachernik, Jiří $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic. jipa@sci.muni.cz.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 10, č. 1 (2020), s. 15922
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32985604 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20240717093503 $b ABA008
- 999 __
- $a ok $b bmc $g 1608144 $s 1118989
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 10 $c 1 $d 15922 $e 20200928 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20210105